crc-22-0489-s02.xlsx (12.13 kB)

Supplementary Table S2 from Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

dataset

posted on 2023-08-30, 14:20 authored by Matjaz Rokavec, Elif Özcan, Jens Neumann, Heiko Hermeking

Supplementary Table S2 shows a subset of 61 genes that were highly significantly associated with survival in CRC patient cohorts.

Funding

Deutschen Konsortium für Translationale Krebsforschung (DKTK)

History

ARTICLE ABSTRACT

We identified and validated a 15-gene expression signature for robust prognostication and stratification of patients with stage II colorectal cancer, with superior performance when compared with currently used biomarkers. Therefore, the 15-gene expression signature has the potential to improve the prognostication and treatment decisions for patients with stage II colorectal cancer.